Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:52:01.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The study on IMU-131 (HER-Vaxx) and chemotherapy has been updated to reflect that results have been posted, changing from a previous status of results submitted.
    Difference
    2%
    Check dated 2025-04-23T08:20:30.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.15.0, replacing the previous version 2.14.4.
    Difference
    1.0%
    Check dated 2025-04-16T01:43:42.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-08T20:18:14.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now indicates that results have been submitted, replacing the previous message that no results were posted.
    Difference
    0.5%
    Check dated 2025-03-25T12:59:21.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T18:19:26.000Z thumbnail image

Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.